MENU
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acrivon Therapeutics (ACRV) Ownership - Who owns Acrivon Therapeutics?

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

Profile

Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
76
Web
https://www.acrivon.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
68.27M
P/E Ratio
N/A
Total Cash
97.74M
Projected Growth
N/A
Total Debt
2.42M
Revenue
N/A
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
2.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
ACRV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
76
Web
https://www.acrivon.com